However, no robust predictive biomarkers for chemotherapy response have entered into routine clinical use, and the inability to predict which patients will respond to chemotherapy represents a major clinical problem, as significant overtreatment of patients not responding is currently performed.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}